An AI-driven "factory of drugs" claims to have hit a big milestone

Zhavoronkov says his drug is special because AI software not only helped decide what target inside a cell to interact with, but also what the drug's chemical structure should be. Popular forms of AI can draw pictures and answer questions. But there's a growing effort to get AI to dream up cures for awful diseases, too. That may be why Jensen Huang, president of Nvidia, which sells AI chips and servers, claimed in December that "digital biology" is going to be the "next amazing revolution" for AI. "This is going to be flat out one of the biggest ones ever," he said.